Panagora Asset Management Inc Sage Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$40.26 - $57.37 $59,464 - $84,735	-1,477 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $6,695 - $9,673	-122 Reduced 7.63%	1,477 $84,000
Q1 2021 May 12, 2021	BUY	$70.65 - $96.76 $97,073 - $132,948	1,374 Added 610.67%	1,599 $120,000
Q4 2020 Feb 10, 2021	SELL	$58.41 - $89.06 $13,784 - $21,018	-236 Reduced 51.19%	225 $19,000
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $4,565 - $6,931	-111 Reduced 19.41%	461 $28,000

Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $5,657 - $9,406	218 Added 61.58%	572 $24,000
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $1,778 - $5,252	68 Added 23.78%	354 $10,000
Q4 2019 Feb 12, 2020	BUY	$60.18 - $154.77 $17,211 - $44,264	286 New	286 $21,000
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $500,664 - $626,935	-3,567 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $542,719 - $686,041	3,567 New	3,567 $575,000

220

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.